Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
01 1Medichem S.A.
02 1Unilab Chemicals and Pharmaceuticals Private Limited
01 2Chlorhexidine Acetate
01 1India
02 1Spain
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0009
Start Marketing Date : 2010-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 25119-0245
Start Marketing Date : 2018-07-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Chlorhexidine Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorhexidine Acetate, including repackagers and relabelers. The FDA regulates Chlorhexidine Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorhexidine Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorhexidine Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorhexidine Acetate supplier is an individual or a company that provides Chlorhexidine Acetate active pharmaceutical ingredient (API) or Chlorhexidine Acetate finished formulations upon request. The Chlorhexidine Acetate suppliers may include Chlorhexidine Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorhexidine Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorhexidine Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorhexidine Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorhexidine Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorhexidine Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorhexidine Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorhexidine Acetate suppliers with NDC on PharmaCompass.
We have 2 companies offering Chlorhexidine Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
